Hydrochloric Acid → 6-Trifluoromethyl-4-[8-(4-morpholin-4-ylphenylamino)imidazo[1,2-a]pyrazin-5-yl]-1H-pyridin-2-one
Reaction equation
C(OC(=O)[N:7]([C:20]1[C:21]2[N:22]([CH:37]=[CH:38][N:39]=2)[C:23]([C:26]2[CH:31]=[C:30]([C:32]([F:35])([F:34])[F:33])[N:29]=[C:28](F)[CH:27]=2)=[CH:24][N:25]=1)[C:8]1[CH:13]=[CH:12][C:11]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)=[CH:10][CH:9]=1)(C)(C)C.CC([O-:45])(C)C.[K+].Cl>C1COCC1.O>[F:33][C:32]([F:35])([F:34])[C:30]1[NH:29][C:28](=[O:45])[CH:27]=[C:26]([C:23]2[N:22]3[CH:37]=[CH:38][N:39]=[C:21]3[C:20]([NH:7][C:8]3[CH:13]=[CH:12][C:11]([N:14]4[CH2:19][CH2:18][O:17][CH2:16][CH2:15]4)=[CH:10][CH:9]=3)=[N:25][CH:24]=2)[CH:31]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of [5-(2-fluoro-6-trifluoromethyl-pyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-(4-morpholin-4-yl-phenyl)carbamic acid tert-butyl ester (92 mg, 0.12 mmol) in THF (0.5 mL) is added KOtBu (26 mg, 0.23 mmol) and the mixture is stirred at rt for 20 min. HCl (12 M aq., 0.1 mL) is added and the mixture is diluted with water (10 mL) and concentrated under reduced pressure. The residue is dissolved in THF (5 mL) and HCl (12 M aq., 0.5 mL) is added and the mixture is stirred at rt for 5 h. NaHCO3 (sat. aq.) is added until the pH is 7 and the mixture is extracted with DCM (3×10 mL). The extracts are dried over Na2SO4 and evaporated under reduced pressure to afford a pale orange solid. This is purified by preparative HPLC to afford the title compound as a yellow solid (9.5 mg). LCMS: Rt=1.04 min (100%), m/z (ESI) 457 (M+H)+.
Workup
- concentrationconcentrated under reduced pressure
- dissolutionThe residue is dissolved in THF (5 mL)
- additionHCl (12 M aq., 0.5 mL) is added
- stirringthe mixture is stirred at rt for 5 h
- additionNaHCO3 (sat. aq.) is added until the pH is 7
- extractionthe mixture is extracted with DCM (3×10 mL)
- dry with materialThe extracts are dried over Na2SO4
- customevaporated under reduced pressure
- customto afford a pale orange solid
- customThis is purified by preparative HPLC
Sources & evidence
- ORD record
- ord-fab0f0b736d948d39a12648fd0e4b3bf
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08173656B2
Reaction notes
Loading…